Clinical Trial Update: Evaluation of the Cryotherapy in the Prevention of Nails Toxicity Induced by Taxotere® in Breast or Prostate Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating cryotherapy to prevent nail toxicity from Taxotere (docetaxel) in breast and prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Prostate Cancer

Drugs mentioned

• Taxotere (docetaxel)

Snippet

Sponsor: Institut Paoli-Calmettes | Conditions: Breast Neoplasms, Prostate Cancer | Phase 3 | Status: COMPLETED